Peter Brooks - QuinStreet Senior President
| QNST Stock | USD 19.59 0.31 1.56% |
President
Mr. Peter Brooks is Senior Vice President of the company. Mr. Brooks has served as our Senior Vice President in charge of the education client vertical since July 2012. Mr. Brooks previously served as our Vice President from July 2010 to July 2012, as our Senior Director from November 2006 to July 2010, as our Director from January 2005 to November 2006, as our Senior Manager from July 2004 to January 2005, as our Manager from April 2003 to July 2004, and as a Business Development Representative from August 2002 to April 2003. Prior to joining us, Mr. Brooks served in various roles managing affiliate relationships and distribution networks at Radio Central, Liquid Audio, Broadcast Music Incorporated, Universal and Atlantic Records, focused on the music industry. He holds a dual B.A in Literature and History from Claremont McKenna College. since 2012.
| Age | 52 |
| Tenure | 13 years |
| Address | 950 Tower Lane, Foster City, CA, United States, 94404 |
| Phone | 650 587 7700 |
| Web | https://www.quinstreet.com |
QuinStreet Management Efficiency
Return On Tangible Assets is likely to gain to -0.17 in 2025. Return On Capital Employed is likely to drop to -0.13 in 2025. Non Current Liabilities Total is likely to gain to about 36.9 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 82.1 M in 2025. QuinStreet's management efficiency ratios could be used to measure how well QuinStreet manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 12 records | PRESIDENT Age | ||
| Ramon Fuenmayor | Phibro Animal Health | N/A | |
| John Swenson | NMI Holdings | N/A | |
| Adam Pollitzer | NMI Holdings | 45 | |
| Bill Morelli | TechTarget, Common Stock | N/A | |
| Rebecca Kitchens | TechTarget, Common Stock | 46 | |
| Michael Giambalvo | Phibro Animal Health | N/A | |
| Thomas Dagger | Phibro Animal Health | 66 | |
| Rob Aukerman | Phibro Animal Health | 67 | |
| Jonathan Bendheim | Phibro Animal Health | 49 | |
| Samson Li | Phibro Animal Health | 53 | |
| Lisa Escudero | Phibro Animal Health | 63 | |
| Daniel Bendheim | Phibro Animal Health | 52 | |
Management Performance
| Return On Equity | -0.0552 | ||||
| Return On Asset | 0.0031 |
QuinStreet Leadership Team
Elected by the shareholders, the QuinStreet's board of directors comprises two types of representatives: QuinStreet inside directors who are chosen from within the company, and outside directors, selected externally and held independent of QuinStreet. The board's role is to monitor QuinStreet's management team and ensure that shareholders' interests are well served. QuinStreet's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, QuinStreet's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Douglas Valenti, President Chairman | ||
| Peter Brooks, Senior President | ||
| Nina Bhanap, CTO and President of Product and Technology | ||
| Stephen Chen, Senior President | ||
| Robert Amparo, Senior Finance | ||
| Martin JD, Chief Officer | ||
| Gregory Wong, CFO and Sr. VP | ||
| Martin Collins, Chief Compliance Officer, Head of Corporate Devel., Sr. VP and General Counsel | ||
| Ashley Heller, Chief Officer | ||
| Jeremy Crisp, Senior Marketing | ||
| Timothy JD, Chief Officer | ||
| Hayden Blair, Sr Relations |
QuinStreet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is QuinStreet a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0552 | ||||
| Return On Asset | 0.0031 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 1.07 B | ||||
| Shares Outstanding | 56.47 M | ||||
| Shares Owned By Insiders | 4.22 % | ||||
| Shares Owned By Institutions | 93.59 % | ||||
| Number Of Shares Shorted | 1.49 M | ||||
| Price To Earning | 24.39 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for QuinStreet Stock Analysis
When running QuinStreet's price analysis, check to measure QuinStreet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy QuinStreet is operating at the current time. Most of QuinStreet's value examination focuses on studying past and present price action to predict the probability of QuinStreet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move QuinStreet's price. Additionally, you may evaluate how the addition of QuinStreet to your portfolios can decrease your overall portfolio volatility.